Very low residual concentrations of rituximab long after infusion still induce positive B-cell complement-dependent cytotoxicity-crossmatch-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Very low residual concentrations of rituximab long after infusion still induce positive B-cell complement-dependent cytotoxicity-crossmatch

Published:2013-12 Issue:12 Volume:74 Page:1616-1618
ISSN:0198-8859
Container-title:Human Immunology
language:en
Short-container-title:Human Immunology

Author:

Philippe Gatault,Isabelle Jollet,Gilles Paintaud,Charlotte Magdelaine,Franck Bridoux,Yvon Lebranchu,Matthias Büchler,Guy Touchard,Antoine Thierry

Publisher

Elsevier BV

Subject

General Medicine,Immunology,Immunology and Allergy

Reference16 articles.

1. Rituximab and intravenous immune globulin for desensitization during renal transplantation;Vo;N Engl J Med,2008

2. The low dose of rituximab in ABO-incompatible kidney transplantation without a splenectomy: a single-center experience;Shirakawa;Clin Transplant,2011

3. Understanding crossmatch testing in organ transplantation: A case-based guide for the general nephrologist;Mulley;Nephrology (Carlton),2011

4. Evaluation of a peptide ELISA for the detection of rituximab in serum;Blasco;J Immunol Methods,2007

5. Rituximab in severe lupus nephritis: early B-cell depletion affects long-term renal outcome;Melander;Clin J Am Soc Nephrol,2009

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imlifidase for Kidney Transplantation of Highly Sensitized Patients With a Positive Crossmatch: The French Consensus Guidelines;Transplant International;2023-06-28

2. The impact of HLA donor-specific antibodies on engraftment and the evolving desensitization strategies;Bone Marrow Transplantation;2022-01-26

3. COVID-19 vaccine does not alter panel reactive antibody or flow cytometric cross match in kidney transplant candidates;Transplant Immunology;2021-12

4. Solid phase-based cross-matching for solid organ transplantation: Currently out-of-stock but urgently required for improved allograft outcome;HISTOL HISTOPATHOL;2020

5. Preoperative Evaluation of Sensitized Patients;Kidney Transplantation in Sensitized Patients;2019-12-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3